title: Lorazepam v. diazepam for pediatric status epilepticus.
abstract: Clinical question Is intravenous (IV) lorazepam superior to IV diazepam in the treatment of pediatric status epilepticus? Article chosen Chamberlain JM, Okada P, Holsti M, et al. Lorazepam v. diazepam for pediatric status epilepticus: a randomized clinical trial. JAMA 2014;311(16):1652-60.
  
  
  OBJECTIVE
  To determine whether lorazepam has better efficacy and safety than diazepam for treating pediatric status epilepticus.
authors.affiliation: *McGill Emergency Medicine Residency Program,McGill University,Montreal,QC.
authors.forename: Rovina Fiona
authors.initials: RF
authors.lastname: Pinto
authors.affiliation: Division of Pediatric Emergency Medicine,Montreal Children's Hospital,McGill University Health Centre,Montreal,QC.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Turnbull
mesh_terms: D000927:Anticonvulsants / Q000627:therapeutic use*; D002675:Child, Preschool; D003975:Diazepam / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D008140:Lorazepam / Q000627:therapeutic use*; D008297:Male; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D013226:Status Epilepticus / Q000188:drug therapy*; D016896:Treatment Outcome; D014481:United States
chemical_list: D000927:Anticonvulsants; D008140:Lorazepam; D003975:Diazepam
keywords: Diazepam; Lorazepam; pediatric; status epilepticus